10311-44-1

Basic information

• Product Name: 2,4-Xylenesulfonamide,3-amino-(7CI,8CI)
• Synonyms: 2,4-Xylenesulfonamide,3-amino-(7CI,8CI)
• CAS NO: 10311-44-1
• Molecular Formula: C8H12N2O2S
• Molecular Weight: 200.25808
• Product Categories: SULFONAMIDE
• Mol File: 10311-44-1.mol
• Article Data: 0

Chemical Properties

• Appearance: /
• CAS DataBase Reference: 2,4-Xylenesulfonamide,3-amino-(7CI,8CI)(CAS DataBase Reference)
• NIST Chemistry Reference: 2,4-Xylenesulfonamide,3-amino-(7CI,8CI)(10311-44-1)
• EPA Substance Registry System: 2,4-Xylenesulfonamide,3-amino-(7CI,8CI)(10311-44-1)

Safety Data

• Hazardous Substances Data: 10311-44-1(Hazardous Substances Data)

Usage

Description

2,4-Xylenesulfonamide,3-amino-(7CI,8CI) is a chemical compound characterized by the molecular formula C8H11NO2S. It is a derivative of 2,4-Xylenesulfonamide, featuring a 3-amino group attached to the benzene ring. This crystalline solid is soluble in organic solvents and has a melting point in the range of 150-154°C. Due to its chemical properties, it is utilized as a raw material in the production of various industrial chemicals, polymers, dyes, pigments, and pharmaceuticals. Careful handling and adherence to safety guidelines are essential when working with this compound.

Uses

Used in Chemical Industry:
2,4-Xylenesulfonamide,3-amino-(7CI,8CI) is used as a raw material for the production of various industrial chemicals and polymers, contributing to the synthesis of a wide range of products due to its reactive functional groups.
Used in Dye and Pigment Manufacturing:
In the dye and pigment industry, 2,4-Xylenesulfonamide,3-amino-(7CI,8CI) serves as a stabilizer and intermediate, enhancing the colorfastness and performance of dyes and pigments in different applications.
Used in Pharmaceutical Production:
2,4-Xylenesulfonamide,3-amino-(7CI,8CI) is utilized as an intermediate in the manufacturing of pharmaceuticals, playing a crucial role in the synthesis of various medicinal compounds, potentially contributing to the development of new drugs.